OppenheimerFunds’s PetMed Express PETS Stock Holding History

OppenheimerFunds’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-4,659	Closed	-$205K	–	1828
2018 Q2	$205K	Buy	+4,659	New	+$180K	﹤0.01%	1763
2018 Q1	–	Sell	-4,442	Closed	-$202K	–	1820
2017 Q4	$202K	Buy	+4,442	New	+$175K	﹤0.01%	1808
2017 Q3	–	Sell	-4,975	Closed	-$202K	–	1867
2017 Q2	$202K	Buy	+4,975	New	+$154K	﹤0.01%	1820

Other funds holding PETS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

OppenheimerFunds's PETS Position: Q3 2018 in Review

OppenheimerFunds sold out of PetMed Express (PETS) in Q3 2018, closing a stake of 4,659 shares — an estimated $205K sold.

OppenheimerFunds first reported a position in PETS in Q2 2017 and held it in 3 quarters. The position peaked at $205K in Q2 2018. 199 funds tracked by Wall St. Rank hold PETS as of Q3 2018.

OppenheimerFunds reported no remaining PetMed Express position as of Q3 2018 after selling out during the quarter.
OppenheimerFunds sold 4,659 PetMed Express shares in Q3 2018, an estimated $205K.
OppenheimerFunds first reported a position in PetMed Express in Q2 2017 and held it in 3 quarters.
OppenheimerFunds's PetMed Express position peaked at $205K in Q2 2018.
199 funds tracked by Wall St. Rank held PetMed Express as of Q3 2018.

Based on OppenheimerFunds's 13F filing for Q3 2018, filed 13 Nov 2018.